共 20 条
Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol
被引:38
作者:

Blum, K. A.
论文数: 0 引用数: 0
h-index: 0
机构:
Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA

Ruppert, A. S.
论文数: 0 引用数: 0
h-index: 0
机构:
Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA

Woyach, J. A.
论文数: 0 引用数: 0
h-index: 0
机构:
Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA

Jones, J. A.
论文数: 0 引用数: 0
h-index: 0
机构:
Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA

Andritsos, L.
论文数: 0 引用数: 0
h-index: 0
机构:
Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA

Flynn, J. M.
论文数: 0 引用数: 0
h-index: 0
机构:
Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA

论文数: 引用数:
h-index:
机构:

Villalona-Calero, M.
论文数: 0 引用数: 0
h-index: 0
机构:
Arthur G James Comprehens Canc Ctr, Div Med Oncol, Dept Internal Med, Columbus, OH USA Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA

Ji, J.
论文数: 0 引用数: 0
h-index: 0
机构:
Ohio State Univ, Div Med Chem & Pharmacol, Coll Pharm, Columbus, OH 43210 USA Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA

论文数: 引用数:
h-index:
机构:

Johnson, A. J.
论文数: 0 引用数: 0
h-index: 0
机构:
Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA

Grever, M. R.
论文数: 0 引用数: 0
h-index: 0
机构:
Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA

Byrd, J. C.
论文数: 0 引用数: 0
h-index: 0
机构:
Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA
Ohio State Univ, Div Med Chem & Pharmacol, Coll Pharm, Columbus, OH 43210 USA Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA
机构:
[1] Ohio State Univ, Div Hematol, Dept Internal Med, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA
[2] Ohio State Univ, Div Nephrol, Dept Internal Med, Columbus, OH 43210 USA
[3] Arthur G James Comprehens Canc Ctr, Div Med Oncol, Dept Internal Med, Columbus, OH USA
[4] Ohio State Univ, Div Med Chem & Pharmacol, Coll Pharm, Columbus, OH 43210 USA
来源:
关键词:
chronic lymphocytic leukemia;
flavopiridol;
tumor lysis syndrome;
CONTINUOUS-INFUSION;
FLUDARABINE;
THERAPY;
CYCLOPHOSPHAMIDE;
GUIDELINES;
MANAGEMENT;
CONSENSUS;
SCHEDULE;
CANCER;
CELLS;
D O I:
10.1038/leu.2011.109
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Tumor lysis syndrome (TLS) has been described in over 40% of patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol. We conducted a retrospective analysis to determine predictive factors for TLS. In 116 patients, the incidence of TLS was 46% (95% CI: 36-55%). In univariable analysis, female gender, greater number of prior therapies, Rai stages III-IV, adenopathy >= 10 cm, splenomegaly, del(11q), decreased albumin and increased absolute lymphocyte count, white blood cell count (WBC), beta 2-microglobulin, and lactate dehydrogenase were associated (P<0.05) with TLS. In multivariable analysis, female gender, adenopathy >= 10 cm, elevated WBC, increased beta 2-microglobulin, and decreased albumin were associated with TLS (P<0.05). With respect to patient outcomes, 49 and 44% of patients with and without TLS, respectively, responded to flavopiridol (P=0.71). In a multivariable analysis, controlling for number of prior therapies, cytogenetics, Rai stage, age and gender, progression-free survival (PFS) was inferior in patients with TLS (P=0.01). Female patients and patients with elevated b2-microglobulin, increased WBC, adenopathy >= 10cm and decreased albumin were at highest risk and should be monitored for TLS with flavopiridol. TLS does not appear to be predictive of response or improved PFS in patients receiving flavopiridol. Leukemia (2011) 25, 1444-1451; doi: 10.1038/leu.2011.109; published online 24 May 2011
引用
收藏
页码:1444 / 1451
页数:8
相关论文
共 20 条
- [1] Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: Results from cancer and leukemia group B study 19805[J]. CLINICAL CANCER RESEARCH, 2005, 11 (11) : 4176 - 4181Byrd, JC论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USAPeterson, BL论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USAGabrilove, J论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USAOdenike, OM论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USAGrever, MR论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USARai, K论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USALarson, RA论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
- [2] Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: Association with increased infusion-related side effects and rapid blood tumor clearance[J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 791 - 795Byrd, JC论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Clin Res Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USAWaselenko, JK论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Clin Res Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USAManeatis, TJ论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Clin Res Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USAMurphy, T论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Clin Res Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USAWard, FT论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Clin Res Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USAMonahan, BP论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Clin Res Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USASipe, MA论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Clin Res Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USADonegan, S论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Clin Res Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USAWhite, CA论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Clin Res Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USA
- [3] Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53[J]. BLOOD, 1998, 92 (10) : 3804 - 3816Byrd, JC论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USAShinn, C论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USAWaselenko, JK论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USAFuchs, EJ论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USALehman, TA论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USANguyen, PL论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USAFlinn, IW论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USADiehl, LF论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USASausville, E论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USAGrever, MR论文数: 0 引用数: 0 h-index: 0机构: Walter Reed Army Med Ctr, Hematol Oncol Serv, Div Hematol Oncol, Washington, DC 20307 USA
- [4] Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia[J]. BLOOD, 2007, 109 (02) : 399 - 404Byrd, John C.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USALin, Thomas S.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USADalton, James T.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USAWu, Di论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USAPhelps, Mitch A.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USAFischer, Beth论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USAMoran, Mollie论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USABlum, Kristie A.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USARovin, Brad论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USABrooker-McEldowney, Michelle论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USABroering, Sarah论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USASchaaf, Larry J.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USAJohnson, Amy J.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USALucas, David M.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USAHeerema, Nyla A.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USALozanski, Gerard论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USAYoung, Donn C.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USASuarez, Jose-Ramon论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USAColevas, A. Dimitrios论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USAGrever, Michael R.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USA
- [5] Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (04) : 578 - 586Cairo, Mitchell S.论文数: 0 引用数: 0 h-index: 0机构: Columbia Univ, Div Blood & Marrow Transplantat, Morgan Stanley Childrens Hosp, Dept Pediat, New York, NY 10027 USA Columbia Univ, Dept Med, Morgan Stanley Childrens Hosp, New York, NY USA Columbia Univ, Dept Pathol, Morgan Stanley Childrens Hosp, New York, NY USA Columbia Univ, Div Blood & Marrow Transplantat, Morgan Stanley Childrens Hosp, Dept Pediat, New York, NY 10027 USACoiffier, Bertrand论文数: 0 引用数: 0 h-index: 0机构: Hosp Civils Lyon, Dept Haematol, Lyon, France Univ Lyon 1, F-69365 Lyon, France Columbia Univ, Div Blood & Marrow Transplantat, Morgan Stanley Childrens Hosp, Dept Pediat, New York, NY 10027 USAReiter, Alfred论文数: 0 引用数: 0 h-index: 0机构: Univ Giessen, Childrens Univ Hosp, Div Paediat Haematol & Oncol, Giessen, Germany Columbia Univ, Div Blood & Marrow Transplantat, Morgan Stanley Childrens Hosp, Dept Pediat, New York, NY 10027 USAYounes, Anas论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Columbia Univ, Div Blood & Marrow Transplantat, Morgan Stanley Childrens Hosp, Dept Pediat, New York, NY 10027 USA
- [6] National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment[J]. BLOOD, 1996, 87 (12) : 4990 - 4997Cheson, BD论文数: 0 引用数: 0 h-index: 0Bennett, JM论文数: 0 引用数: 0 h-index: 0Grever, M论文数: 0 引用数: 0 h-index: 0Kay, N论文数: 0 引用数: 0 h-index: 0Keating, MJ论文数: 0 引用数: 0 h-index: 0OBrien, S论文数: 0 引用数: 0 h-index: 0Rai, KR论文数: 0 引用数: 0 h-index: 0
- [7] Tumor lysis syndrome: An uncommon complication of fludarabine therapy of chronic lymphocytic leukemia[J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (07) : 2313 - 2320Cheson, BD论文数: 0 引用数: 0 h-index: 0机构: NCI, Div Canc Diag & Treatment, Canc Therapy Evaluat Program, Bethesda, MD 20892 USAFrame, JN论文数: 0 引用数: 0 h-index: 0机构: NCI, Div Canc Diag & Treatment, Canc Therapy Evaluat Program, Bethesda, MD 20892 USAVena, D论文数: 0 引用数: 0 h-index: 0机构: NCI, Div Canc Diag & Treatment, Canc Therapy Evaluat Program, Bethesda, MD 20892 USAQuashu, N论文数: 0 引用数: 0 h-index: 0机构: NCI, Div Canc Diag & Treatment, Canc Therapy Evaluat Program, Bethesda, MD 20892 USASorensen, JM论文数: 0 引用数: 0 h-index: 0机构: NCI, Div Canc Diag & Treatment, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA
- [8] Guidelines for the management of pediatric and adult tumor lysis syndrome: An evidence-based review[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) : 2767 - 2778Coiffier, Bertrand论文数: 0 引用数: 0 h-index: 0机构: Hosp Civils Lyon, Dept Hematol, Lyon, FranceAltman, Arnold论文数: 0 引用数: 0 h-index: 0机构: Hosp Civils Lyon, Dept Hematol, Lyon, FrancePui, Ching-Hon论文数: 0 引用数: 0 h-index: 0机构: Hosp Civils Lyon, Dept Hematol, Lyon, FranceYounes, Anas论文数: 0 引用数: 0 h-index: 0机构: Hosp Civils Lyon, Dept Hematol, Lyon, FranceCairo, Mitchell S.论文数: 0 引用数: 0 h-index: 0机构: Hosp Civils Lyon, Dept Hematol, Lyon, France
- [9] TUMOR LYSIS SYNDROME FOLLOWING TREATMENT WITH 2-CHLORODEOXYADENOSINE FOR REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (21) : 1547 - 1548DANN, EJ论文数: 0 引用数: 0 h-index: 0机构: HADASSAH UNIV HOSP,DEPT PATHOL,IL-91120 JERUSALEM,ISRAEL HADASSAH UNIV HOSP,DEPT PATHOL,IL-91120 JERUSALEM,ISRAELGILLIS, S论文数: 0 引用数: 0 h-index: 0机构: HADASSAH UNIV HOSP,DEPT PATHOL,IL-91120 JERUSALEM,ISRAEL HADASSAH UNIV HOSP,DEPT PATHOL,IL-91120 JERUSALEM,ISRAELPOLLIACK, A论文数: 0 引用数: 0 h-index: 0机构: HADASSAH UNIV HOSP,DEPT PATHOL,IL-91120 JERUSALEM,ISRAEL HADASSAH UNIV HOSP,DEPT PATHOL,IL-91120 JERUSALEM,ISRAELOKON, E论文数: 0 引用数: 0 h-index: 0机构: HADASSAH UNIV HOSP,DEPT PATHOL,IL-91120 JERUSALEM,ISRAEL HADASSAH UNIV HOSP,DEPT PATHOL,IL-91120 JERUSALEM,ISRAELRUND, D论文数: 0 引用数: 0 h-index: 0机构: HADASSAH UNIV HOSP,DEPT PATHOL,IL-91120 JERUSALEM,ISRAEL HADASSAH UNIV HOSP,DEPT PATHOL,IL-91120 JERUSALEM,ISRAELRACHMILEWITZ, EA论文数: 0 引用数: 0 h-index: 0机构: HADASSAH UNIV HOSP,DEPT PATHOL,IL-91120 JERUSALEM,ISRAEL HADASSAH UNIV HOSP,DEPT PATHOL,IL-91120 JERUSALEM,ISRAEL
- [10] Genomic aberrations and survival in chronic lymphocytic leukemia.[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) : 1910 - 1916Döhner, H论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Dept Internal Med 3, D-89081 Ulm, GermanyStilgenbauer, S论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Dept Internal Med 3, D-89081 Ulm, GermanyBenner, A论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Dept Internal Med 3, D-89081 Ulm, GermanyLeupolt, E论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Dept Internal Med 3, D-89081 Ulm, GermanyKröber, A论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Dept Internal Med 3, D-89081 Ulm, GermanyBullinger, L论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Dept Internal Med 3, D-89081 Ulm, GermanyDöhner, K论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Dept Internal Med 3, D-89081 Ulm, GermanyBentz, M论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Dept Internal Med 3, D-89081 Ulm, GermanyLichter, P论文数: 0 引用数: 0 h-index: 0机构: Univ Ulm, Dept Internal Med 3, D-89081 Ulm, Germany